NCT05695612

Brief Summary

The aim of the study is to evaluate clinically and radiographically the Novaloc and Locator attachment systems in mandibular overdentures retained with two inclined implants.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 10, 2022

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

January 13, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 25, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

January 25, 2023

Status Verified

January 1, 2023

Enrollment Period

1.2 years

First QC Date

January 13, 2023

Last Update Submit

January 13, 2023

Conditions

Outcome Measures

Primary Outcomes (5)

  • Peri-implant Probing Depth (PD)

    The distance from the gingival margin till the point of least resistance will be measured using a graduated plastic autoclavable periodontal probe. The probe will be held parallel to the long axis of the implant and introduced with light force to the peri-implant sulcus. Measurements will be made at 6 sites around each implant; mesiobuccal, mid-buccal, disto-buccal, mesio-palatal, mid-palatal and disto-palatal. Probing depth of 1 mm or less will be recorded as 1 mm, and those exceeding 1 mm, but less than 2 mm, will be recorded as 2 mm, and so on. The mean for each implant will be calculated.

    up to 12 months

  • Modified Sulcus Bleeding Index (BI)

    This will be measured using a graduated plastic autoclavable periodontal probe. The probe will be held parallel to the long axis of the implant and introduced with light force to the peri-implant sulcus. A score of 0-3 will be assigned to each labial and palatal surface of the implant then the average for each implant will be calculated according to the following criteria: Score 0: No bleeding when a periodontal probe is passed along the gingival margin adjacent to the implant. Score 1: Isolated bleeding spots visible. Score 2: Blood forms a confluent red line on margin. Score 3: Heavy or profuse bleeding

    up to 12 months

  • Modified gingival index

    The peri-implant mucosal tissues will be assessed according to Lobene and Weatherford as follows: 0: Absence of inflammation, normal gingiva. 1. Mild inflammation, slight color change, little change in texture of any portion of, but not entire, marginal, or papillary gingival unit (localized). 2. Mild inflammation, slight color change, little change in texture involving the entire or papillary gingival unit (generalized).. 3. Moderate inflammation, redness, and edema. 4. Severe inflammation, marked redness, edema, ulceration, and spontaneous bleeding It will be measured at 4 sites around each implant (mesially, distally, labially/ buccaly, lingually) then, the mean record will be calculated for each implant. Indices of the two implants will be added to each other, and then divided by 2 to get the mean modified gingival index for each case.

    up to 12 months

  • Alveolar bone level

    The level of alveolar bone around each implant will be assessed using CBCT(3D Accuitomo 170, 90 kVp, 5 mA, 30.8 s, 0.08 mm isotropic voxel size, J Morita, Kyoto, Japan) and the field of view will be the lower anterior sextant. The vertical bone change (distance from the implant platform to the first bone-to-implant contact, in mm) around each implant will be assessed at the buccal, lingual, mesial and distal aspects then the mean will be calculated.

    up to 12 months

  • Implant stability

    Magnetic Resonance Frequency Analyser will be used to measure the implant stability quotient (ISQ). The instrument measures the resonance frequency through the transducer attached to a implant fixture and display the result ISQ value on a scale of 1 to 100 with higher values indicating higher stability. The measurements will be made three times and the mean will be calculated.

    up to 12 months

Study Arms (2)

Novaloc Attachment

EXPERIMENTAL
Other: Novaloc Attachment

Locator attachment

ACTIVE COMPARATOR
Other: Locator Attachment

Interventions

Each patient will receive two inclined implants placed in the mandibular canine region bilaterally using the flapless surgical technique. Patients will receive mandibular overdentures with Novaloc attachments. The proper Novaloc abutments will be selected and screwed on the implants according to the prosthetic platform and the tissue height. The metal housings will be connected to the existing mandibular overdenture by pick-up technique.

Novaloc Attachment

Each patient will receive two inclined implants placed in the mandibular canine region bilaterally using the flapless surgical technique. Patients will receive mandibular overdentures with Locator attachments. The proper Locator abutments will be selected and screwed on the implants according to the prosthetic platform and the tissue height. The metal housings will be connected to the existing mandibular overdenture by pick-up technique.

Locator attachment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients should be completely edentulous.
  • Patients should have enough bone for the placement of implants at least 3.5 mm in diameter and 10.0 mm in length.
  • Patients should be co-operative and have adequate dexterity for placement and removal of the implant -retained overdenture.
  • The inter-ridge space should be sufficient to place the endosseous implants and the superstructures

You may not qualify if:

  • Patients with any systematic disease that could complicate the surgical phase or affect osseointegration as osteoporosis and uncontrolled diabetes mellitus.
  • Patients with active oral infections.
  • Patients with history of radiotherapy in head and neck region.
  • Patients with poor oral hygiene.
  • Patients with restricted mouth openings ≤ 40mm, functional limitations, or temporo-mandibular disorders.
  • Heavy smokers (more than 10 cigarette / day).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Alexandria University

Alexandria, 21527, Egypt

RECRUITING

Study Officials

  • Haitham Ismail, MSc

    Alexandria University

    PRINCIPAL INVESTIGATOR
  • Ahmed Al-Shimy, PhD

    Alexandria University

    STUDY DIRECTOR
  • Tarek S Abdelazim, PhD

    Alexandria University

    STUDY CHAIR
  • Kenda IH Hanno, PhD

    Alexandria University

    STUDY CHAIR

Central Study Contacts

Haitham Ismail, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer of Prosthodontics

Study Record Dates

First Submitted

January 13, 2023

First Posted

January 25, 2023

Study Start

March 10, 2022

Primary Completion

June 1, 2023

Study Completion

June 1, 2023

Last Updated

January 25, 2023

Record last verified: 2023-01

Locations